I

Ipsen
IPN

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€8.08B
EV
€7.92B
Shares Outstanding
82.20M
Beta
0.40

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
€125.47
P/E 2025E
9.19x
P/Revenue 2025E
2.10x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Ipsen S.A.

gainify

I

Ipsen S.A.

IPN

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of secon...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Loew, David

Employees

5,358

IPO Date

2005-12-07

Headquarters

65, quai Georges Gorse, Boulogne-Billancourt, Ile-de-France, 92100, France

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved